2. Search Result
Search Result
Pathways Recommended: Antibody-drug Conjugate/ADC Related
Results for "

MRG002 antibody

" in MedChemExpress (MCE) Product Catalog:

2

Inhibitors & Agonists

1

Inhibitory Antibodies

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-164992
    Trastuzumab vedotin

    MRG002; Trastuzumab MMAE

    		 Antibody-Drug Conjugates (ADCs) EGFR Microtubule/Tubulin Cancer
    Trastuzumab vedotin (MRG002) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab vedotin is composed of a humanized anti-HER2 antibody Trastuzumab (HY-P9907), an enzymatically cleavable peptide-linker Valine-citrulline, a tubulin inhibitor Monomethyl auristatin E (MMAE; HY-15162). Trastuzumab vedotin can be used for the research of HER2-positive breast cancer .
    Trastuzumab vedotin
  • HY-P991509
    MAB802

    MRG002 antibody

    		 EGFR ADC Antibody Cancer
    MAB802 (MRG002 antibody) is a recombinant humanized anti-HER2 monoclonal antibody. MAB802 shares the same amino acid sequence as Trastuzumab (HY-P9907) but is hyper-fucosylated. MAB802 has reduced antibody-dependent cell-mediated cytotoxicity (ADCC) activity. MAB802 can be used as an ADC antibody component of Trastuzumab vedotin (MRG002) (HY-164992) .
    MAB802

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: